{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T10:31:31Z","timestamp":1783420291936,"version":"3.54.6"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T00:00:00Z","timestamp":1661558400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T00:00:00Z","timestamp":1661558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007102","name":"Zagazig University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007102","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hyperthyroidism is associated with cardiac hypertrophy, fibrosis, and increased risk of cardiovascular mortality. Sacubitril\/valsartan (LCZ696) is a new combined drug that has shown promise for the treatment of hyperthyroidism-associated heart failure; however, the underlying molecular mechanisms, including the contributions of epigenetic regulation, remain unclear. The present study was designed to investigate the therapeutic efficacy of LCZ696 and the potential contributions of microRNA regulation in a rat model of hyperthyroidism-induced cardiac hypertrophy. Cardiac hypertrophy was induced by intraperitoneal administration of levothyroxine. Sixty adult male Wistar rats were randomly allocated to four equal groups (15 rats each): control, cardiac hypertrophy (CH), CH\u2009+\u2009valsartan, and CH\u2009+\u2009LCZ696. Treatment with LCZ696 or valsartan significantly improved hemodynamic abnormalities, normalized serum concentrations of natriuretic peptide, fibroblast growth factor-23, and cardiac inflammatory markers compared to CH group rats. Treatment with LCZ696 or valsartan also normalized myocardial expression levels of autophagy markers, fibrotic markers, <jats:italic>PPAR-\u03d2, mir-377, and let-7b<\/jats:italic>. In addition, both valsartan and LCZ696 ameliorated collagen deposition, ventricular degeneration, and various ultrastructural abnormalities induced by levothyroxine. The beneficial effects of LCZ696 were superior to those of valsartan alone. The superior efficacy of LCZ696 may be explained by the stronger modulation of <jats:italic>miR-377<\/jats:italic> and <jats:italic>let-7b<\/jats:italic>.<\/jats:p>","DOI":"10.1038\/s41598-022-18860-y","type":"journal-article","created":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T18:02:47Z","timestamp":1661623367000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Sacubitril\/valsartan (LCZ696) ameliorates hyperthyroid-induced cardiac hypertrophy in male rats through modulation of miR-377, let-7 b, autophagy, and fibrotic signaling pathways"],"prefix":"10.1038","volume":"12","author":[{"given":"Tarek","family":"Khamis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amira Ebrahim","family":"Alsemeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doaa M.","family":"Abdullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,27]]},"reference":[{"key":"18860_CR1","doi-asserted-by":"publisher","first-page":"R59","DOI":"10.1530\/EC-19-0543","volume":"9","author":"MLM Barreto-Chaves","year":"2020","unstructured":"Barreto-Chaves, M. L. M., Senger, N., Fevereiro, M. R., Parletta, A. C. & Takano, A. P. C. Impact of hyperthyroidism on cardiac hypertrophy. Endocr. Connect. 9, R59\u2013R69 (2020).","journal-title":"Endocr. Connect."},{"key":"18860_CR2","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.amjmed.2014.03.009","volume":"127","author":"IM Grais","year":"2014","unstructured":"Grais, I. M. & Sowers, J. R. Thyroid and the heart. Am. J. Med. 127, 691\u2013698 (2014).","journal-title":"Am. J. Med."},{"key":"18860_CR3","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/nrcardio.2016.174","volume":"14","author":"A Jabbar","year":"2016","unstructured":"Jabbar, A. et al. Thyroid hormones and cardiovascular disease. Nat. Rev. Cardiol. 14, 39\u201355 (2016).","journal-title":"Nat. Rev. Cardiol."},{"key":"18860_CR4","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s00424-017-2088-6","volume":"470","author":"APC Takano","year":"2018","unstructured":"Takano, A. P. C., Senger, N., Munhoz, C. D. & Barreto-Chaves, M. L. M. AT1 receptor blockage impairs NF-\u03baB activation mediated by thyroid hormone in cardiomyocytes. Pflug. Arch. Eur. J. Physiol. 470, 549\u2013558 (2018).","journal-title":"Pflug. Arch. Eur. J. Physiol."},{"key":"18860_CR5","first-page":"276","volume":"8","author":"R Pakdel","year":"2018","unstructured":"Pakdel, R. et al. A comparison between the effects of Portulaca oleracea seeds extract and valsartan on echocardiographic and hemodynamic parameters in rats with levothyroxine-induced thyrotoxicosis. Avicenna J. Phytomed. 8, 276\u2013285 (2018).","journal-title":"Avicenna J. Phytomed."},{"key":"18860_CR6","doi-asserted-by":"publisher","first-page":"4714","DOI":"10.3390\/ijms20194714","volume":"20","author":"N Wehbe","year":"2019","unstructured":"Wehbe, N. et al. MicroRNAs in cardiac hypertrophy. Int. J. Mol. Sci. 20, 4714 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"18860_CR7","doi-asserted-by":"publisher","first-page":"6771","DOI":"10.1080\/21655979.2021.1964892","volume":"12","author":"Y Ding","year":"2021","unstructured":"Ding, Y., Wang, J. & Lu, J. miR-337-5p promotes the development of cardiac hypertrophy by targeting Ubiquilin-1 (UBQLN1). Bioengineered 12, 6771\u20136781 (2021).","journal-title":"Bioengineered"},{"key":"18860_CR8","doi-asserted-by":"publisher","first-page":"588347","DOI":"10.3389\/fcvm.2020.588347","volume":"7","author":"S Saadat","year":"2021","unstructured":"Saadat, S. et al. Pivotal role of TGF-\u03b2\/Smad signaling in cardiac fibrosis: Non-coding RNAs as effectual players. Front. Cardiovasc. Med. 7, 588347 (2021).","journal-title":"Front. Cardiovasc. Med."},{"key":"18860_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5402\/2012\/927064","volume":"2012","author":"M Badadani","year":"2012","unstructured":"Badadani, M. Autophagy mechanism, regulation, functions, and disorders. ISRN Cell Biol. 2012, 1\u201311 (2012).","journal-title":"ISRN Cell Biol."},{"key":"18860_CR10","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1093\/abbs\/gmw025","volume":"48","author":"L Li","year":"2016","unstructured":"Li, L. et al. The role of autophagy in cardiac hypertrophy. Acta Biochim. Biophys. Sin. 48, 491\u2013500 (2016).","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"18860_CR11","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.mce.2010.12.018","volume":"333","author":"ASR Araujo","year":"2011","unstructured":"Araujo, A. S. R. et al. Reactive oxygen and nitrogen species balance in the determination of thyroid hormones-induced cardiac hypertrophy mediated by renin-angiotensin system. Mol. Cell. Endocrinol. 333, 78\u201384 (2011).","journal-title":"Mol. Cell. Endocrinol."},{"key":"18860_CR12","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s00018-013-1349-6","volume":"71","author":"P Kong","year":"2014","unstructured":"Kong, P., Christia, P. & Frangogiannis, N. G. The pathogenesis of cardiac fibrosis. Cell. Mol. Life Sci. 71, 549\u2013574 (2014).","journal-title":"Cell. Mol. Life Sci."},{"key":"18860_CR13","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/nrcardio.2014.64","volume":"11","author":"NE Zois","year":"2014","unstructured":"Zois, N. E. et al. Natriuretic peptides in cardiometabolic regulation and disease. Nat. Rev. Cardiol. 11, 403\u2013412 (2014).","journal-title":"Nat. Rev. Cardiol."},{"key":"18860_CR14","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.cardfail.2017.12.010","volume":"24","author":"Y Suematsu","year":"2018","unstructured":"Suematsu, Y. et al. LCZ696 (Sacubitril\/Valsartan), an angiotensin-receptor neprilysin inhibitor, attenuates cardiac hypertrophy, fibrosis, and vasculopathy in a rat model of chronic kidney disease. J. Card. Fail. 24, 266\u2013275 (2018).","journal-title":"J. Card. Fail."},{"key":"18860_CR15","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/7256862","author":"Q Ge","year":"2020","unstructured":"Ge, Q. et al. LCZ696, an angiotensin receptor-neprilysin inhibitor, improves cardiac hypertrophy and fibrosis and cardiac lymphatic remodeling in transverse aortic constriction model mice. Biomed. Res. Int. https:\/\/doi.org\/10.1155\/2020\/7256862 (2020).","journal-title":"Biomed. Res. Int."},{"key":"18860_CR16","first-page":"1878","volume":"11","author":"W Ding","year":"2020","unstructured":"Ding, W., Feng, H., Li, W. J., Liao, H. H. & Tang, Q. Z. Research progress on the interaction between autophagy and energy homeostasis in cardiac remodeling. Front. Pharmacol. 11, 1878 (2020).","journal-title":"Front. Pharmacol."},{"key":"18860_CR17","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1161\/01.RES.0000179226.34112.6d","volume":"97","author":"SZ Duan","year":"2005","unstructured":"Duan, S. Z., Ivashchenko, C. Y., Russell, M. W., Milstone, D. S. & Mortensen, R. M. Cardiomyocyte-specffic knockout and agonist of peroxisome proliferator-activated receptor-\u03b3 both induce cardiac hypertrophy in mice. Circ. Res. 97, 372\u2013379 (2005).","journal-title":"Circ. Res."},{"key":"18860_CR18","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/nrcardio.2017.35","volume":"14","author":"LMD Delbridge","year":"2017","unstructured":"Delbridge, L. M. D., Mellor, K. M., Taylor, D. J. & Gottlieb, R. A. Myocardial stress and autophagy: Mechanisms and potential therapies. Nat. Rev. Cardiol. 14, 412\u2013425 (2017).","journal-title":"Nat. Rev. Cardiol."},{"key":"18860_CR19","doi-asserted-by":"publisher","first-page":"e12542","DOI":"10.1111\/jpi.12542","volume":"66","author":"Y Zhang","year":"2019","unstructured":"Zhang, Y. et al. Melatonin attenuates myocardial ischemia-reperfusion injury via improving mitochondrial fusion\/mitophagy and activating the AMPK-OPA1 signaling pathways. J. Pineal Res. 66, e12542 (2019).","journal-title":"J. Pineal Res."},{"key":"18860_CR20","first-page":"1","volume":"4","author":"A Lilienbaum","year":"2013","unstructured":"Lilienbaum, A. Relationship between the proteasomal system and autophagy. Int. J. Biochem. Mol. Biol. 4, 1 (2013).","journal-title":"Int. J. Biochem. Mol. Biol."},{"key":"18860_CR21","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1177\/1535370219861283","volume":"244","author":"Q Ge","year":"2019","unstructured":"Ge, Q., Zhao, L., Ren, X. M., Ye, P. & Hu, Z. Y. LCZ696, an angiotensin receptor-neprilysin inhibitor, ameliorates diabetic cardiomyopathy by inhibiting inflammation, oxidative stress and apoptosis. Exp. Biol. Med. (Maywood). 244, 1028\u20131039 (2019).","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"18860_CR22","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1002\/ehf2.13177","volume":"8","author":"ES Nord\u00e9n","year":"2021","unstructured":"Nord\u00e9n, E. S. et al. Sacubitril\/valsartan ameliorates cardiac hypertrophy and preserves diastolic function in cardiac pressure overload. ESC Hear. Fail. 8, 918\u2013927 (2021).","journal-title":"ESC Hear. Fail."},{"key":"18860_CR23","doi-asserted-by":"publisher","first-page":"4092","DOI":"10.1080\/21655979.2021.1953212","volume":"12","author":"Z Li","year":"2021","unstructured":"Li, Z., Xu, C. & Sun, D. MicroRNA-488 serves as a diagnostic marker for atherosclerosis and regulates the biological behavior of vascular smooth muscle cells. Bioengineered 12, 4092\u20134099 (2021).","journal-title":"Bioengineered"},{"key":"18860_CR24","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1080\/26895293.2020.1808083","volume":"13","author":"J Shao","year":"2020","unstructured":"Shao, J. et al. MiR-377 accelerates cardiac hypertrophy by inhibiting autophagy via targeting PPAR\u03b3. All Life 13, 456\u2013465. https:\/\/doi.org\/10.1080\/26895293.2020.1808083 (2020).","journal-title":"All Life"},{"key":"18860_CR25","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/cdd.2008.163","volume":"16","author":"K Nishida","year":"2009","unstructured":"Nishida, K., Kyoi, S., Yamaguchi, O., Sadoshima, J. & Otsu, K. The role of autophagy in the heart. Cell Death Differ. 16, 31\u201338 (2009).","journal-title":"Cell Death Differ."},{"key":"18860_CR26","first-page":"699","volume":"12","author":"C-B Zheng","year":"2021","unstructured":"Zheng, C.-B. et al. Ang II promotes cardiac autophagy and hypertrophy via Orai1\/STIM1. Front. Pharmacol. 12, 699 (2021).","journal-title":"Front. Pharmacol."},{"key":"18860_CR27","doi-asserted-by":"publisher","first-page":"e015640","DOI":"10.1161\/JAHA.119.015640","volume":"9","author":"E Vaskova","year":"2020","unstructured":"Vaskova, E. et al. Sacubitril\/valsartan improves cardiac function and decreases myocardial fibrosis via downregulation of exosomal mir-181a in a rodent chronic myocardial infarction model. J. Am. Heart Assoc. 9, e015640 (2020).","journal-title":"J. Am. Heart Assoc."},{"key":"18860_CR28","first-page":"1775","volume":"17","author":"Y Zhang","year":"2018","unstructured":"Zhang, Y. et al. Matrine suppresses cardiac fibrosis by inhibiting the TGF-\u03b2\/Smad pathway in experimental diabetic cardiomyopathy. Mol. Med. Rep. 17, 1775\u20131781 (2018).","journal-title":"Mol. Med. Rep."},{"key":"18860_CR29","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.1161\/01.CIR.0000130641.08705.45","volume":"109","author":"JR McMullen","year":"2004","unstructured":"McMullen, J. R. et al. Inhibition of mTOR signaling with rapamycin regresses established cardiac hypertrophy induced by pressure overload. Circulation 109, 3050\u20133055 (2004).","journal-title":"Circulation"},{"key":"18860_CR30","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1152\/ajpheart.00145.2017","volume":"313","author":"X Wang","year":"2017","unstructured":"Wang, X. & Cui, T. Heart failure: Novel therapeutic pathways emerging from basic science: Autophagy modulation: A potential therapeutic approach in cardiac hypertrophy. Am. J. Physiol. Heart Circ. Physiol. 313, 304 (2017).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"18860_CR31","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.4161\/auto.7.11.17339","volume":"7","author":"H Su","year":"2011","unstructured":"Su, H. & Wang, X. Autophagy and p62 in cardiac protein quality control. Autophagy 7, 1382 (2011).","journal-title":"Autophagy"},{"key":"18860_CR32","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3389\/fcvm.2017.00029","volume":"4","author":"C Zhang","year":"2017","unstructured":"Zhang, C., Syed, T. W., Liu, R. & Yu, J. Role of endoplasmic reticulum stress, autophagy, and inflammation in cardiovascular disease. Front. Cardiovasc. Med. 4, 29 (2017).","journal-title":"Front. Cardiovasc. Med."},{"key":"18860_CR33","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1161\/CIRCRESAHA.111.244707","volume":"109","author":"Q Zheng","year":"2011","unstructured":"Zheng, Q., Su, H., Ranek, M. J. & Wang, X. Autophagy and p62 in cardiac proteinopathy. Circ. Res. 109, 296\u2013308 (2011).","journal-title":"Circ. Res."},{"key":"18860_CR34","doi-asserted-by":"publisher","first-page":"e50926","DOI":"10.1371\/journal.pone.0050926","volume":"7","author":"G Long","year":"2012","unstructured":"Long, G. et al. Circulating miR-30a, miR-195 and let-7b associated with acute myocardial infarction. PLoS ONE 7, e50926 (2012).","journal-title":"PLoS ONE"},{"key":"18860_CR35","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1507\/endocrj.EJ12-0111","volume":"59","author":"BH Kim","year":"2012","unstructured":"Kim, B. H. et al. Irbesartan prevents myocardial remodeling in experimental thyrotoxic cardiomyopathy. Endocr. J. 59, 919\u2013929 (2012).","journal-title":"Endocr. J."},{"key":"18860_CR36","doi-asserted-by":"publisher","first-page":"165577","DOI":"10.1016\/j.bbadis.2019.165577","volume":"1866","author":"T Khamis","year":"2020","unstructured":"Khamis, T. et al. Early intervention with breast milk mesenchymal stem cells attenuates the development of diabetic-induced testicular dysfunction via hypothalamic Kisspeptin\/Kiss1r-GnRH\/GnIH system in male rats. Biochim. Biophys. Acta Mol. Basis Dis. 1866, 165577 (2020).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"18860_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.174188","volume":"905","author":"T Khamis","year":"2021","unstructured":"Khamis, T. et al. Breast milk MSCs upregulated \u03b2-cells PDX1, Ngn3, and PCNA expression via remodeling ER stress \/inflammatory \/apoptotic signaling pathways in type 1 diabetic rats. Eur. J. Pharmacol. 905, 174188 (2021).","journal-title":"Eur. J. Pharmacol."},{"key":"18860_CR38","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/nprot.2008.73","volume":"3","author":"TD Schmittgen","year":"2008","unstructured":"Schmittgen, T. D. & Livak, K. J. Analyzing real-time PCR data by the comparative CT method. Nat. Protoc. 3, 1101\u20131108 (2008).","journal-title":"Nat. Protoc."},{"key":"18860_CR39","volume-title":"Theory and Practice of Histological Techniques. 6th ed. 2007. Techniques in Histopathology and Cytopathology","author":"JD Bancroft","year":"2008","unstructured":"Bancroft, J. D. & Gamble, M. Theory and Practice of Histological Techniques. 6th ed. 2007. Techniques in Histopathology and Cytopathology (Churchill Livingstone, 2008)."},{"key":"18860_CR40","volume-title":"Electron Microscopy: Principles and Techniques for Biologists","author":"JJ Bozzola","year":"1992","unstructured":"Bozzola, J. J. & Russell, L. D. Electron Microscopy: Principles and Techniques for Biologists (Jones and Bartlett Publishers, 1992)."},{"key":"18860_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.174188","author":"T Khamis","year":"2021","unstructured":"Khamis, T. et al. Breast milk MSCs upregulated \u03b2-cells PDX1, Ngn3, and PCNA expression via remodeling ER stress \/inflammatory \/Apoptotic signaling pathways in type 1 diabetic rats. Eur. J. Pharmacol. https:\/\/doi.org\/10.1016\/j.ejphar.2021.174188 (2021).","journal-title":"Eur. J. Pharmacol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18860-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18860-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18860-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T18:02:56Z","timestamp":1661623376000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18860-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,27]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["18860"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-18860-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,27]]},"assertion":[{"value":"27 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14654"}}